CAVAX
Price
$19.12
Change
+$0.21 (+1.11%)
Updated
Sep 11 closing price
Net Assets
454.74M
RWEBX
Price
$67.02
Change
+$0.28 (+0.42%)
Updated
Sep 11 closing price
Net Assets
218.5B
Interact to see
Advertisement

CAVAX vs RWEBX

CAVAX vs RWEBX Comparison Chart in %
View a ticker or compare two or three
VS
CAVAX vs. RWEBX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAVAX is a Buy and RWEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 218B vs. CAVAX (455M). RWEBX (0.74) and CAVAX (0.74) have matching dividends . CAVAX was incepted earlier than RWEBX: CAVAX (11 years) vs RWEBX (12 years). CAVAX (1.07) and RWEBX (1.06) have similar cost to investors . RWEBX is a more actively managed with annual turnover of: 32.00 vs. CAVAX (21.00). RWEBX has a lower initial minimum investment than CAVAX: RWEBX (250) vs CAVAX (500). CAVAX annual gain was more profitable for investors over the last year : 8.19 vs. RWEBX (1.26). RWEBX return over 5 years is better than : 23.43 vs. CAVAX (14.66).
CAVAXRWEBXCAVAX / RWEBX
Total Expense Ratio0.711.0667%
Annual Report Gross Expense Ratio1.071.06101%
Fund Existence11 years12 years-
Gain YTD11.5633.934294%
Front LoadN/AN/A-
Min. Initial Investment500250200%
Min. Initial Investment IRAN/AN/A-
Net Assets455M218B0%
Annual Yield % from dividends0.740.7499%
Returns for 1 year8.191.26649%
Returns for 3 years45.0527.16166%
Returns for 5 years14.6623.4363%
Returns for 10 years113.6075.35151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CANF2.330.17
+7.87%
Can-Fite Biopharma Ltd
SEER1.950.02
+1.04%
Seer
MTSI274.902.47
+0.91%
MACOM Technology Solutions Holdings
ASH70.910.21
+0.30%
Ashland
MDXG4.57-0.03
-0.65%
MiMedx Group